The neurodegenerative disease landscape is undergoing unprecedented transformation as the global community confronts the mounting challenge of Alzheimer’s disease. With demographic shifts creating an expanding patient population, the Alzheimer’s Disease Drugs Market has become a focal point for innovative therapeutic development and strategic investment across the pharmaceutical industry. Current Market Landscape and Revenue Projections The Read.